For patients who require mesalamine delivered to and throughout the colon13
Lialda is the first and only once-daily oral 5-ASA approved for the induction of
remission in patients with active, mild to moderate ulcerative colitis (UC). Safety
and effectiveness of Lialda beyond 8 weeks have not been established.
Learn more at www.lialda.com